Profile data is unavailable for this security.
About the company
22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.
- Revenue in USD (TTM)29.75m
- Net income in USD-62.89m
- Incorporated2005
- Employees64.00
- Location22nd Century Group Inc8560 Main St Ste 4WILLIAMSVILLE 14221-7435United StatesUSA
- Phone+1 (716) 270-1523
- Fax+1 (716) 877-3064
- Websitehttps://www.xxiicentury.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BioNexus Gene Lab Corp | 9.78m | -2.66m | 9.61m | 30.00 | -- | 1.03 | -- | 0.9832 | -0.14 | -0.14 | 0.651 | 0.5289 | 1.01 | 8.55 | 5.80 | -- | -27.53 | -3.83 | -33.16 | -5.02 | 13.56 | 14.55 | -27.25 | -3.04 | 3.98 | -162.45 | 0.00 | -- | -10.60 | 115.07 | -638.56 | -- | 30.40 | -- |
| Enzon Pharmaceuticals Inc | 0.00 | 221.00k | 9.65m | 0.00 | 43.62 | 2.93 | -- | -- | 0.003 | 0.003 | 0.00 | 0.624 | 0.00 | -- | -- | -- | 3.21 | -0.8654 | 3.24 | -0.8851 | -- | -- | -- | -159.43 | -- | -- | 0.00 | -- | -100.00 | -- | 106.71 | -55.86 | -- | -- |
| Galera Therapeutics Inc | 0.00 | -45.75m | 9.68m | 7.00 | -- | -- | -- | -- | -0.9971 | -0.9971 | 0.00 | -2.48 | 0.00 | -- | -- | 0.00 | -115.30 | -83.69 | -142.79 | -97.54 | -- | -- | -- | -- | -- | -6.49 | 9.23 | -- | -- | -- | 5.05 | -- | -29.84 | -- |
| Coeptis Therapeutics Holdings Inc | 0.00 | -16.31m | 9.69m | 5.00 | -- | 2.18 | -- | -- | -0.5804 | -0.5804 | 0.00 | 0.1197 | 0.00 | -- | -- | 0.00 | -212.70 | -36.90 | -378.58 | -37.81 | -- | -- | -- | -- | -- | -- | 0.349 | -- | -- | -- | 43.40 | -- | -- | -- |
| Oragenics Inc | 20.63k | -20.26m | 9.77m | 5.00 | -- | 9.46 | -- | 473.48 | -7.98 | -7.98 | 0.0079 | 0.5859 | 0.0026 | -- | -- | 4,126.00 | -258.71 | -97.60 | -312.34 | -106.24 | -- | -- | -98,214.93 | -36,169.75 | -- | -- | 0.0461 | -- | -71.37 | -- | -44.56 | -- | 51.64 | -- |
| 22nd Century Group Inc | 29.75m | -62.89m | 10.37m | 64.00 | -- | -- | -- | 0.3485 | -40.02 | -97.93 | 17.94 | -3.23 | 0.40 | 5.90 | 5.47 | 464,796.90 | -66.29 | -46.78 | -92.49 | -54.18 | -33.09 | -2.11 | -165.75 | -107.95 | 0.4284 | -3.67 | 4.76 | -- | -20.49 | 4.03 | -76.94 | -- | 53.60 | -- |
| Cannapharmarx Inc | 0.00 | 3.69m | 10.53m | 21.00 | 1.97 | -- | 2.76 | -- | 0.0081 | 0.0081 | 0.00 | -0.028 | 0.00 | -- | -- | 0.00 | 42.99 | -131.06 | -- | -- | -- | -- | -- | -- | 0.0034 | -1.03 | -- | -- | -- | -- | 143.24 | -- | -- | -- |
| Allarity Therapeutics Inc | 0.00 | -20.94m | 10.56m | 5.00 | -- | -- | -- | -- | -599.34 | -599.34 | 0.00 | -18.88 | 0.00 | -- | -- | 0.00 | -100.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.02 | -- | -- | -- |
| Eterna Therapeutics Inc | 115.00k | -22.92m | 10.77m | 8.00 | -- | -- | -- | 93.62 | -4.25 | -4.25 | 0.0214 | -0.6307 | 0.0036 | -- | 0.2305 | 14,375.00 | -70.71 | -169.05 | -88.77 | -223.00 | -114.78 | -- | -19,912.17 | -682.61 | -- | -15.55 | 1.64 | -- | -- | -68.89 | 11.84 | -- | -58.86 | -- |
| Monopar Therapeutics Inc | 0.00 | -7.61m | 10.84m | 10.00 | -- | 1.45 | -- | -- | -0.5289 | -0.5289 | 0.00 | 0.4277 | 0.00 | -- | -- | 0.00 | -73.36 | -54.07 | -92.67 | -60.60 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 20.10 | -- | -- | -- |
| Psyence Biomedical Ltd | 0.00 | 1.52m | 11.06m | -- | -- | -- | 7.30 | -- | -0.0442 | -0.0442 | 0.00 | -0.3979 | 0.00 | -- | -- | -- | 1.13 | -- | 1.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.63 | -- | -- | -- |
| GlucoTrack Inc | 0.00 | -8.74m | 11.07m | 6.00 | -- | 28.75 | -- | -- | -1.87 | -1.87 | 0.00 | 0.0703 | 0.00 | -- | -- | 0.00 | -520.58 | -94.01 | -2,110.63 | -142.35 | -- | -- | -- | -10,447.96 | -- | -- | 0.3415 | -- | -- | -- | -60.02 | -- | -- | -- |
| Enzolytics Inc | 0.00 | -119.19k | 11.16m | 2.00 | -- | -- | -- | -- | -0.106 | -0.106 | 0.00 | -1.04 | 0.00 | -- | -- | -- | -369.52 | -- | -- | -- | -- | -- | -- | -- | -- | -4.30 | -- | -- | -100.00 | -- | -9.35 | -- | -- | -- |
Data as of May 23 2024. Currency figures normalised to 22nd Century Group Inc's reporting currency: US Dollar USD
5.76%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Anson Funds Management LPas of 31 Mar 2024 | 411.11k | 4.96% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 13.10k | 0.16% |
| Geode Capital Management LLCas of 31 Mar 2024 | 11.95k | 0.14% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 11.85k | 0.14% |
| Group One Trading LPas of 31 Mar 2024 | 7.74k | 0.09% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 5.24k | 0.06% |
| Two Sigma Investments LPas of 31 Mar 2024 | 5.16k | 0.06% |
| Andina Capital Management LLCas of 31 Mar 2024 | 4.30k | 0.05% |
| G1 Execution Services LLCas of 31 Mar 2024 | 3.85k | 0.05% |
| XTX Markets LLCas of 31 Mar 2024 | 3.31k | 0.04% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
